Cord blood transplantation for acute myelogenous leukemia using a conditioning regimen consisting of granulocyte colony-stimulating factor-combined high-dose cytarabine, fludarabine, and total body irradiation

European Journal of Haematology

Volumn 77, Issue 1, 2006, Pages 46-50

  Tomonari, Akira ^a   Takahashi, Satoshi ^a   Ooi, Jun ^a   Nakaoka, Takashi ^a   Takasugi, Kashiya ^a   Uchiyama, Michihiro ^a   Tsukada, Nobuhiro ^a   Konuma, Takaaki ^a   Iseki, Tohru ^a   Tojo, Arinobu ^a   Asano, Shigetaka ^a,b  

^a UNIVERSITY OF TOKYO   (Japan)

^b WASEDA UNIVERSITY   (Japan)

Author keywords

Acute myelogenous leukemia; Cord blood; Cytarabine; Granulocyte colony stimulating factor; Transplantation cardiac dysfunction

Indexed keywords

ACICLOVIR; AMPHOTERICIN B LIPID COMPLEX; ANTIBIOTIC AGENT; CYCLOSPORIN; CYTARABINE; FLUDARABINE; GANCICLOVIR; ITRACONAZOLE; METHOTREXATE; MICAFUNGIN; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; ARTICLE; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; CORD BLOOD STEM CELL TRANSPLANTATION; CYTOMEGALOVIRUS INFECTION; DISEASE SEVERITY; FEMALE; FOLLOW UP; GASTROINTESTINAL TOXICITY; GRAFT VERSUS HOST REACTION; HERPES SIMPLEX; HERPES ZOSTER; HUMAN; LEUKEMIA RELAPSE; LUNG ASPERGILLOSIS; MALE; NEUTROPHIL COUNT; POSTOPERATIVE COMPLICATION; POSTOPERATIVE INFECTION; PRIORITY JOURNAL; SEPSIS; STOMATITIS; TREATMENT OUTCOME; WHOLE BODY RADIATION;

ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; ASPERGILLOSIS; COMBINED MODALITY THERAPY; CORD BLOOD STEM CELL TRANSPLANTATION; CYTARABINE; DISEASE-FREE SURVIVAL; FEMALE; GRAFT VS HOST DISEASE; GRANULOCYTE COLONY-STIMULATING FACTOR; HUMANS; LEUKEMIA, MYELOCYTIC, ACUTE; MALE; MIDDLE AGED; SEPSIS; STOMATITIS; TRANSPLANTATION CONDITIONING; VIDARABINE; WHOLE-BODY IRRADIATION;

EID: 33745015498     PISSN: 09024441     EISSN: 16000609     Source Type: Journal    
DOI: 10.1111/j.0902-4441.2006.t01-1-EJH2608.x     Document Type: Article

References (18)

1. Takahashi S Okamoto S Shirafuji N et al. Recombinant human glycosylated granulocyte colony stimulating factor (rhG-CSF)-combined regimen for allogeneic bone marrow transplantation in refractory acute myeloid leukemia. Bone Marrow Transplant 1994 13 : 239 245.
2. Miyauchi J Kelleher CA Wang C Minkin S McCulloch EA. Growth factors influence the sensitivity of leukemic stem cells to cytosine arabinoside in culture. Blood 1989 73 : 1272 1278.
3. Takahashi S Oshima Y Okamoto S Nishiwaki K Nagayama H Inoue T Tojo A Tani K Asano S. Recombinant human granulocyte colony-stimulating factor (G-CSF) combined conditioning regimen for allogeneic bone marrow transplantation (BMT) in standard-risk myeloid leukemia. Am J Hematol 1998 57 : 303 308.
4. Okamoto S Takahashi S Wakui M Ishida A Tanosaki R Ikeda Y Asano S. Treatment of advanced myelodysplastic syndrome with a regimen including recombinant human granulocyte colony-stimulating factor preceding allogeneic bone marrow transplantation. Br J Haematol 1999 104 : 569 573.
5. Laughlin MJ Eapen M Rubinstein P et al. Outcomes after transplantation of cord blood or bone marrow from unrelated donors in adults with leukemia. N Engl J Med 2004 351 : 2265 2275.
6. Rocha V Labopin M Sanz G et al. Acute Leukemia Working Party of European Blood and Marrow Transplant Group; Eurocord-Netcord Registry. Transplants of umbilical-cord blood or bone marrow from unrelated donors in adults with acute leukemia. N Engl J Med 2004 351 : 2276 2285.
7. Ooi J Iseki T Takahashi S et al. Unrelated cord blood transplantation for adult patients with de novo acute myeloid leukemia. Blood 2004 103 : 489 491.
8. Ooi J Iseki T Takahashi S et al. Unrelated cord blood transplantation for adult patients with advanced myelodysplastic syndrome. Blood 2003 101 : 4711 4713.
9. Takahashi S Iseki T Ooi J et al. Single-institute comparative analysis of unrelated bone marrow transplantation and cord blood transplantation for adult patients with hematologic malignancies. Blood 2004 104 : 3813 3820.
10. Goldberg MA Antin JH Guinan EC Rappeport JM. Cyclophosphamide cardiotoxicity: an analysis of dosing as a risk factor. Blood 1986 68 : 1114 1118.
11. Fujimaki K Maruta A Yoshida M et al. Severe cardiac toxicity in hematological stem cell transplantation: predictive value of reduced left ventricular ejection fraction. Bone Marrow Transplant 2001 27 : 307 310.
12. Rubinstein P Carrier C Scaradavou A et al. Outcomes among 562 recipients of placental-blood transplants from unrelated donors. N Engl J Med 1998 339 : 1565 1577.
13. Tomonari A Iseki T Ooi J et al. Cytomegalovirus infection following unrelated cord blood transplantation for adult patients: a single institute experience in Japan. Br J Haematol 2003 121 : 304 311.
14. Bearman SI Appelbaum FR Buckner CD Petersen FB Fisher LD Clift RA Thomas ED. Regimen-related toxicity in patients undergoing bone marrow transplantation. J Clin Oncol 1988 6 : 1562 1568.
15. Przepiorka D Weisdorf D Martin P Klingemann HG Beatty P Hows J Thomas ED. Consensus conference on acute GVHD grading. Bone Marrow Transplant 1995 15 : 825 828.
16. Sullivan KM Agura E Anasetti C et al. Chronic graft-versus-host disease and other late complications of bone marrow transplantation. Semin Hematol 1991 28 : 250 259.
17. Lehmann S Isberg B Ljungman P Paul C. Cardiac systolic function before and after hematopoietic stem cell transplantation. Bone Marrow Transplant 2000 26 : 187 192.
18. Hertenstein B Stefanic M Schmeiser T Scholz M Goller V Clausen M Bunjes D Wiesneth M Novotny J Kochs M. Cardiac toxicity of bone marrow transplantation: predictive value of cardiologic evaluation before transplant. J Clin Oncol 1994 12 : 998 1004.